Ana Fernández‐Teijeiro

Author

Hospital Universitario Virgen Macarena ORCID

Also Known As

A Fernández-Teijeiro, A. Fernandez-Teijeiro, A. Fernandez‐Teijeiro, A. Fernández-Teijeiro, A. Fernández-Teijeiro Álvarez, A. Fernández‑Teijeiro, Ana Fernandez-Teijeiro, Ana Fernández-Teijeiro, Ana Fernández-Teijeiro, Ana Fernández-Teijeiro Álvarez

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen Macarena University Hospital in Motol University Hospital of Lausanne Leipzig University Karolinska University Hospital

About

Ana Fernández‐Teijeiro is an author at Hospital Universitario Virgen Macarena specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	418
2	Health Sciences	1	1	156
3	Public Health	1	1	22
4	Allergy	1	1	22
5	Cell Biology	1	1	44

Ana Fernández‐Teijeiro

Publications

839

Citations

H-Index

Page 1

	Year	Citations
qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma Dirk Hasenclever, Lars Kurch, Christine Mauz‐Körholz, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyDeauville ScaleLymphoid NeoplasiaOncologic ImagingMedical Imaging	2014	156
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries Ido Didi Fabian, Abdallah Elhassan, Shehu U. Abdullahi, The Lancet Global Health	2022	135
Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in Medulloblastomas Ana Fernández‐Teijeiro, Rebecca A. Betensky, Lisa Marie Sturla, Journal of Clinical Oncology	2004	84
Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome‐positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL‐94, ALL‐99 and ALL‐2005 Susana Rives, Jesús Estella, Pedro Gómez, British Journal of Haematology	2011	55
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma Regine Kluge, Lidia Chavdarova, Martha Hoffmann, PLoS ONE	2016	55
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries Andrew W. Stacey, Richard Bowman, Allen Foster, Ophthalmology OphthalmologyMedicinePathologyGlaucomaRetinoblastoma Has	2021	48
Familial retinoblastoma due to intronic LINE-1 insertion causes aberrant and noncanonical mRNA splicing of the RB1 gene Carlos Rodriguez‐Martin, Florencia Cidre‐Aranaz, Ana Fernández‐Teijeiro, Journal of Human Genetics Transcriptional RegulationIntronic Line-1 InsertionFamilial RetinoblastomaRb1 GeneGenetic Disorder	2016	44
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study Christine Mauz‐Körholz, Judith Landman‐Parker, Ana Fernández‐Teijeiro, The Lancet Oncology Adaptive RadiotherapyLymphoid NeoplasiaOncologyRadiation TherapyResponse-adapted Omission	2023	44
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries Ido Didi Fabian, Andrew W. Stacey, Allen Foster, British Journal of Ophthalmology	2020	33
Secondary central nervous system metastases in children with neuroblastoma Itziar Astigarraga, R. Lejarreta, Aurora Navajas, Medical and Pediatric Oncology Neuro-oncologyPediatric Brain TumorsBrain MetastasesPediatric NeurosurgeryMedicine	1996	27

Page 1